Hi Misiu,
In my opinion if FDA comes back with some new
Hi Misiu,
In my opinion if FDA comes back with some new requirement when 2nd part of BLA is supposed to be filed, it would kind of worry me that they are holding it up on purpose. Especially since efficacy is in the 40's on 2 drugs with major side effects already approved. I can understand the FDA coming up and saying, since you want to use this test with your patients to determine how many mg to use, we need data from the 700mg patients as well. Maybe they are going to get all 3 dosages approved, and that is why Nadar said, you will understand when it all happens. This is all in my opinion though, but seems the most logical.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sivers Semiconductors Announces Partnership with DigiKey In an exciting development for the tech industry, Sivers Semiconductors AB (STO:SIVE), known for its expertise in photonics and wireless technologies, has formed a strategic partnership with DigiKey. This collaboration is designed to enhance the accessibility of Sivers' cutting-edge millimeter-wave products and...
Continue Reading
Alternative Shipping Solutions Amid Canada Post Disruptions Asendia USA is stepping up to provide a robust alternative for e-commerce retailers in the USA facing challenges while shipping to Canada due to the ongoing disruptions with Canada Post. This timely initiative is especially critical as businesses gear up for the busy peak season. Why Many Retailers Are Seeking...
Continue Reading
U.N. Highlights Possible Violations of Humanitarian Law in Ukraine By Max Hunder As Ukraine prepares for a harsh winter, the United Nations has issued grave warnings about Russia's air strikes targeting the nation's energy infrastructure. A report from a U.N. monitoring body suggests these attacks may violate international humanitarian law, raising concerns about the...
Continue Reading
The Launch of Maya: A New Era for Career Assistance Maya is an innovative AI-powered tool designed to enhance career exploration and guidance. The Muse, a well-established source for employment insights, proudly announces this launch, aimed at providing more personalized advice to users seeking career growth. How Maya Works Maya leverages generative AI to deliver tailored...
Continue Reading
Google's Antitrust Trial on Ad Tech Dominance Alphabet Inc. (NASDAQ: GOOGL), the parent company of Google, is currently embroiled in a significant legal battle as it prepares to face U.S. antitrust prosecutors over its practices in online advertising technology. This trial, held in a federal court, centers on allegations that Google has engaged in activities that suppress...
Continue Reading
